US Stock ProPhase Labs Surges Over 35%, Market Cap Reaches $15.78 Million

BlockBeats News, August 13th, according to Rockflow data, U.S. medical technology company ProPhase Labs surged over 35% intraday, with a market value rising to $15.78 million. It had previously surged over 40% in pre-market trading.

ProPhase Labs had announced on July 21st that it is exploring a reverse merger with a cryptocurrency-focused company and will start holding Bitcoin as part of its new digital asset reserve strategy.